Adipogenic action of vanadium: a new dimension in treating diabetes

[1]  S. Padhye,et al.  Reduction of oxidative stress induced vanadium toxicity by complexing with a flavonoid, quercetin: A pragmatic therapeutic approach for diabetes , 2006, Biometals.

[2]  A. Srivastava,et al.  Insulino‐mimetic and anti‐diabetic effects of vanadium compounds , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[3]  S. Padhye,et al.  Synthesis, structural properties and insulin-enhancing potential of bis(quercetinato)oxovanadium(IV) conjugate. , 2004, Bioorganic & medicinal chemistry letters.

[4]  V. Fonseca.  Effect of thiazolidinediones on body weight in patients with diabetes mellitus. , 2003, The American journal of medicine.

[5]  S. Pandey,et al.  Prolongation of insulin-induced activation of mitogen-activated protein kinases ERK 1/2 and phosphatidylinositol 3-kinase by vanadyl sulfate, a protein tyrosine phosphatase inhibitor. , 2003, Archives of biochemistry and biophysics.

[6]  F. Gregoire.  Adipocyte Differentiation: From Fibroblast to Endocrine Cell , 2001, Experimental biology and medicine.

[7]  P. Watson,et al.  Insulin-induced Adipocyte Differentiation , 2001, The Journal of Biological Chemistry.

[8]  J. McNeill,et al.  Effect of vanadium on insulin sensitivity and appetite. , 2001, Metabolism: clinical and experimental.

[9]  G. Hausman,et al.  Enhancing effect of troglitazone on porcine adipocyte differentiation in primary culture: a comparison with dexamethasone. , 2000, Obesity research.

[10]  Beliaeva Nf,et al.  [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus]. , 2000 .

[11]  A. Srivastava.  Anti-diabetic and toxic effects of vanadium compounds , 2000, Molecular and Cellular Biochemistry.

[12]  C. Kahn,et al.  Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. , 2000, Metabolism: clinical and experimental.

[13]  J. Reusch,et al.  CREB Activation Induces Adipogenesis in 3T3-L1 Cells , 2000, Molecular and Cellular Biology.

[14]  G. Boden,et al.  15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene. , 1999, Metabolism: clinical and experimental.

[15]  J. Reusch,et al.  Insulin Stimulates cAMP-response Element Binding Protein Activity in HepG2 and 3T3-L1 Cell Lines* , 1998, The Journal of Biological Chemistry.

[16]  H. Sul,et al.  Understanding adipocyte differentiation. , 1998, Physiological reviews.

[17]  S. Tafuri.  Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes. , 1996, Endocrinology.

[18]  G. Boden,et al.  Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. , 1996, Metabolism: clinical and experimental.

[19]  M. Sonenberg,et al.  Role of insulin in growth hormone-stimulated 3T3 cell adipogenesis. , 1988, Endocrinology.

[20]  J. Smith,et al.  Vanadium ions stimulate DNA synthesis in Swiss mouse 3T3 and 3T6 cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Dubyak,et al.  Insulin-mimetic effects of vanadate in isolated rat adipocytes , 1980 .

[22]  S. Pandey,et al.  Insulin signal mimicry as a mechanism for the insulin-like effects of vanadium , 2006, Cell Biochemistry and Biophysics.

[23]  M. A. Golubev,et al.  [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus]. , 2000, Voprosy meditsinskoi khimii.